Practical Permeability-Based Hepatic Clearance Classification System (Hepccs) in Drug Discovery

References

• Wu CY , BenetLZ. Predicting drug disposition via application of BCS. Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res.22 (1), 11–23 (2005).
   PubMed Web of Science ®Google Scholar
• Rowland M , TozerT. Clinical Pharmacokinetics Concepts and Applications (3rd Edition).Lippincott Williams & Wilkins, PA, USA, 109–117 (1995).
   Google Scholar
• Obach RS . Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab. Dispos.27 (11), 1350–1359 (1999).
   PubMed Web of Science ®Google Scholar
• Jones HM , HoustonJB. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Drug Metab. Dispos.32 (9), 973–982 (2004).
   PubMed Web of Science ®Google Scholar
• Mcginnity DF , SoarsMG, UrbanowiczRA, RileyRJ. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab. Dispos.32 (11), 1247–1253 (2004).
   PubMed Web of Science ®Google Scholar
• Austin RP , BartonP, CockroftSL, WenlockMC, RileyRJ. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab. Dispos.30 (12), 1497–1503 (2002).
   PubMed Web of Science ®Google Scholar
• Obach RS , Reed-HagenAE. Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metab. Dispos.30 (7), 831–837 (2002).
   PubMed Web of Science ®Google Scholar
• Pang KS , WeissM, MacherasP. Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts. AAPS J.9 (2), E268–E283 (2007).
   PubMed Web of Science ®Google Scholar
• Pang KS , MaengHJ, FanJ. Interplay of transporters and enzymes in drug and metabolite processing. Mol. Pharm.6 (6), 1734–1755 (2009).
   PubMedGoogle Scholar
• Kusuhara H , SugiyamaY. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Drug Metab. Rev.42 (3), 539–550 (2010).
   PubMed Web of Science ®Google Scholar
• Houston JB . Transporters and cytochrome P450 interplay in defining hepatic drug clearance. In : 4th European Cyprotex Drug Discovery Workshop. London, UK, 9June 2010.
   Google Scholar
• Umehara K , CamenischG. Novel in vitro–in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm. Res.29 (2), 603–617 (2012).
   PubMed Web of Science ®Google Scholar
• Thwaites DT , HirstBH, SimmonsNL. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines. Pharm. Res.10 (5), 674–681 (1993).
   PubMed Web of Science ®Google Scholar
• Irvine JD , TakahashiL, LockhartKet al. MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci.88 (1), 28–33 (1999).
   PubMed Web of Science ®Google Scholar
• Huang L , BerryL, GangaSet al. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance. Drug Metab. Dispos.38 (2), 223–231 (2010).
   PubMed Web of Science ®Google Scholar
• Soars MG , WebbornPJ, RileyRJ. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol. Pharm.6 (6), 1662–1677 (2009).
   PubMed Web of Science ®Google Scholar
• Watanabe T , KusuharaH, MaedaKet al. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab. Dispos.38 (2), 215–222 (2010).
   PubMed Web of Science ®Google Scholar
• Halladay JS , WongS, JafferSM, SinhababuAK, Khojasteh-BakhtSC. Metabolic stability screen for drug discovery using cassette analysis and column switching. Drug Metab. Lett.1 (1), 67–72 (2007).
   PubMedGoogle Scholar
• Jacobson L , MiddletonB, HolmgrenJet al. An optimized automated assay for determination of metabolic stability using hepatocytes: assay validation, variance component analysis, and in vivo relevance. Assay Drug Dev. Technol.5 (3), 403–415 (2007).
   PubMed Web of Science ®Google Scholar
• Lau YY , OkochiH, HuangY, BenetLZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metab. Dispos.34 (7), 1175–1181 (2006).
   PubMed Web of Science ®Google Scholar
• Berezhkovskiy LM . The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations. J. Pharm. Sci.100 (11), 5031–5047 (2011).
   PubMed Web of Science ®Google Scholar
• Fagerholm U . Presentation of a modified dispersion model (MDM) for hepatic drug extraction and a new methodology for the prediction of the rate-limiting step in hepatic metabolic clearance. Xenobiotica39 (1), 57–71 (2009).
   PubMed Web of Science ®Google Scholar
• Koepsell H , LipsK, VolkC. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res.24 (7), 1227–1251 (2007).
   PubMed Web of Science ®Google Scholar
• Soars MG , GrimeK, SprostonJL, WebbornPJ, RileyRJ. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab. Dispos.35 (6), 859–865 (2007).
   PubMed Web of Science ®Google Scholar
• Feng B , MillsJB, DavidsonREet al. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Drug Metab. Dispos.36 (2), 268–275 (2008).
   PubMed Web of Science ®Google Scholar
• Hallifax D , HoustonJB. Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. Drug Metab. Dispos.35 (8), 1325–1332 (2007).
   PubMed Web of Science ®Google Scholar
• Amidon GL , LennernasH, ShahVP, CrisonJR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res.12 (3), 413–420 (1995).
   PubMed Web of Science ®Google Scholar
• Brown HS , WilbyAJ, AlderJ, HoustonJB. Comparative use of isolated hepatocytes and hepatic microsomes for cytochrome P450 inhibition studies: transporter-enzyme interplay. Drug Metab. Dispos.38 (12), 2139–2146 (2010).
   PubMed Web of Science ®Google Scholar
• Paine SW , ParkerAJ, GardinerP, WebbornPJ, RileyRJ. Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Drug Metab. Dispos.36 (7), 1365–1374 (2008).
   PubMed Web of Science ®Google Scholar
• Huang L , ChenA, RobertsJet al. Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds. Xenobiotica42 (9), 830–840 (2012).
   PubMed Web of Science ®Google Scholar